Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: AIDS. 2020 May 1;34(6):849–857. doi: 10.1097/QAD.0000000000002484

Figure 2.

Figure 2.

Heatmap showing correlation coefficients between EBV and CMV DNA at each time point with various soluble (A) and cellular (B) markers of inflammation, immune activation, and gut damage among controls at baseline (A: N=125–147, B: N=110), year 1 (A: N=254–276, B: N=267), and pre-event (A: N=215–237, B: N=184). * indicated statistical significance at p<0.05.